CSIRO Publishing Books Journals About Us Shopping Cart You are here: Journals > Australian Journal of Chemistry   
Australian Journal of Chemistry
  An international journal for chemical science
 
Search
 
 
  Advanced Search
   

Journal Home
About the Journal
Editorial Board
Contacts
For Advertisers
Content
Online Early
Current Issue
Just Accepted
All Issues
Special Issues
Research Fronts
Sample Issue
Covers
For Authors
General Information
Notice to Authors
Submit Article
Open Access
For Referees
General Information
Review Article
For Subscribers
Subscription Prices
Customer Service
Print Publication Dates

 Early Alert
Subscribe to our Email Alert or RSS feeds for the latest journal papers.

 Connect with us
facebook   youtube

Affiliated with RACI

Royal Australian Chemical Institute
Royal Australian
Chemical Institute


 

Article << Previous     |     Next >>   Contents Vol 60(8)

Copper(ii) Complexes with Reduced Schiff Base: Synthesis, Spectroscopic, Thermal, X-Ray, and Cytotoxic Studies of Novel Copper(ii) Complexes with an Arylpyrazole Ligand

Vukadin M. Leovac A, Petra Bombicz B, Katalin Mészáros Szécsényi A, Milan D. Joksović D D

A Faculty of Sciences, University of Novi Sad, Trg D. Obradovića 3, 21000 Novi Sad, Serbia.
B Institute of Structural Chemistry, Chemical Research Center, Hungarian Academy of Sciences, PO Box 17, H-1525 Budapest, Hungary.
C Faculty of Sciences, University of Kragujevac, R. Domanovica 12, 34000 Kragujevac, Serbia.
D Corresponding author. Email: mjoksovic@kg.ac.yu
 
PDF (431 KB) $25
 Export Citation
 Print
  


Abstract

The synthesis of a novel arylpyrazole-derived ligand, 1,2-bis[(1,3-diphenylpyrazol-4-yl)methyl]diaminoethane (Ph4Pz2mde), and its complexes prepared with CuCl2 [Cu(Ph4Pz2mde)Cl2(MeOH)] 1, CuBr2 [Cu(Ph4Pz2mde)Br2(MeOH)] 2, from MeOH, and [Cu(Ph4Pz2mde)Cl2(DMF)] 3, from a mixture of MeOH and DMF, are described. The complexes are characterized by elemental and thermal analysis and FT-IR spectroscopy, while the 1H and 13C NMR assignments are given for the ligand. The crystal and molecular structure of [Cu(Ph4Pz2mde)Cl2(DMF)] was determined by single-crystal X-ray diffraction. In-vitro cytotoxicity of the Ph4Pz2mde ligand and two copper(ii) complexes was obtained using sulforhodamine B (SRB) treatment against three human tumour cell lines: HeLa (epitheloid carcinoma of cervix), MCF-7 (breast adenocarcinoma), and MRC-5 (lung fetal fibroblasts).

   
Subscriber Login
Username:
Password:  

    


 
Top  Email this page
 
Legal & Privacy | Contact Us | Help

CSIRO

© CSIRO 1996-2012